Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.35 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 3/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.32 |
| ▸ | TTK | P33981 | 1/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15914729 | 0.93 | CYP3A4 (0.36) | CYP3A4MKNK1MKNK2KDM1AHRH4 | |
| SCHEMBL15914754 | 0.91 | ALDH1A1 (0.37) | KDM1ACYP11B1CYP11B2SLC2A1 | |
| SCHEMBL15914937 | 0.86 | SLC2A1 (0.46) | CYP3A4MKNK1MKNK2HRH4HTR1A | |
| SCHEMBL15914611 | 0.86 | SLC2A1 (0.46) | CYP3A4MKNK1MKNK2HRH4HTR1A | |
| SCHEMBL15914678 | 0.85 | CHEK1 (0.36) | CYP3A4MKNK1MKNK2KDM1ACHEK1 | |
| SCHEMBL15914574 | 0.84 | SLC2A1 (0.39) | CYP3A4MKNK1MKNK2KDM1AHRH4 | |
| SCHEMBL15914747 | 0.84 | SLC2A1 (0.39) | CYP3A4MKNK1MKNK2KDM1AHRH4 | |
| SCHEMBL15914869 | 0.84 | CYP3A4 (0.35) | CYP3A4MKNK1MKNK2KDM1AHRH4 | |
| SCHEMBL15914177 | 0.83 | HRH4 (0.37) | CYP3A4MKNK1MKNK2KDM1AHRH4 | |
| SCHEMBL15914073 | 0.82 | MKNK1 (0.46) | CYP3A4MKNK1MKNK2HRH4HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140221354-A1 | IMIDAZO [1,2-a]PYRIDINE COMPOUNDS FOR USE IN THERAPY | EMBLEM TECHNOLOGY TRANSFER GMBH (DE) | 2014-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221354-A1 | IMIDAZO [1,2-a]PYRIDINE COMPOUNDS FOR USE IN THERAPY | HIF1A, HIF1AN, EGLN3 | CYP3A4 1281/4885MKNK1 3718/4885MKNK2 3782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.